Literature DB >> 15064969

[Implant exposure after viscocanalostomy with reticulated hyaluronic acid (SK-GEL)].

C Lüke1, T S Dietlein, S Roters, P C Jacobi, W Konen, G K Krieglstein.   

Abstract

BACKGROUND: Lately, the application of intrascleral implants has been increasingly discussed to improve success rates of nonpenetrating surgery for the treatment of open-angle glaucoma. PATIENTS AND METHODS: A 36-year-old male patient with medically uncontrolled pigmentary glaucoma underwent viscocanalostomy with intrascleral implantation of reticulated hyaluronic acid (SK-GEL) in his right eye.
RESULTS: The immediate postoperative course was unremarkable with control of intraocular pressure without additional glaucoma medications. At first follow-up, 2 weeks post surgery, conjunctival dehiscence with partial extrusion and exposure of the reticulated hyaluronic acid implant was observed. Under topical tobramycin ointment a gradual limbal readaptation of the conjunctiva over the surface of the exposed parts of the implant with formation of a filtration bleb was noted. Therefore, surgical revision remained unnecessary.
CONCLUSIONS: Implant exposure following nonpenetrating antiglaucomatous surgery is a specific complication, which can appear whenever intrascleral implants are used. Depending on the local situation nonsurgical treatment may be successful.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15064969     DOI: 10.1007/s00347-004-0999-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  11 in total

1.  Nonpenetrating filtration surgery for glaucoma: control by surgery only.

Authors:  E Dahan; M U Drusedau
Journal:  J Cataract Refract Surg       Date:  2000-05       Impact factor: 3.351

2.  "New" surgical treatments for glaucoma.

Authors:  P T Khaw; D Siriwardena
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

3.  Viscocanalostomy for primary open-angle glaucoma: the Gross Pankow experience.

Authors:  M U Drüsedau; K von Wolff; H Bull; B von Barsewisch
Journal:  J Cataract Refract Surg       Date:  2000-09       Impact factor: 3.351

4.  Scleral ectasia as a complication of deep sclerectomy.

Authors:  S Milazzo; P Turut; D Malthieu; M A Leviel
Journal:  J Cataract Refract Surg       Date:  2000-05       Impact factor: 3.351

5.  [Comparative results of deep sclerectomy transformed to trabeculectomy and classical trabeculectomy].

Authors:  E Sanchez; C C Schnyder; A Mermoud
Journal:  Klin Monbl Augenheilkd       Date:  1997-05       Impact factor: 0.700

6.  Intracorneal inclusion of high-molecular-weight sodium hyaluronate following detachment of Descemet's membrane during viscocanalostomy.

Authors:  C Lüke; T Dietlein; P Jacobi; W Konen; G K Krieglstein
Journal:  Cornea       Date:  2000-07       Impact factor: 2.651

7.  Reticulated hyaluronic acid implant in nonperforating trabecular surgery.

Authors:  P Sourdille; P Y Santiago; F Villain; M Yamamichi; H Tahi; J M Parel; Y Ducournau
Journal:  J Cataract Refract Surg       Date:  1999-03       Impact factor: 3.351

8.  A prospective randomized trial of viscocanalostomy versus trabeculectomy in open-angle glaucoma: a 1-year follow-up study.

Authors:  Christoph Lüke; Thomas S Dietlein; Philipp C Jacobi; Walter Konen; Günter K Krieglstein
Journal:  J Glaucoma       Date:  2002-08       Impact factor: 2.503

9.  Viscocanalostomy: a pilot study.

Authors:  R G Carassa; P Bettin; M Fiori; R Brancato
Journal:  Eur J Ophthalmol       Date:  1998 Apr-Jun       Impact factor: 1.922

View more
  2 in total

1.  [Classification of biomedical research reports as a reference for evidence-based medicine in ophthalmology. A survey considering as example the journal Der Ophthalmologe].

Authors:  H P N Scholl; M Fleckenstein; T U Krohne; F G Holz
Journal:  Ophthalmologe       Date:  2005-12       Impact factor: 1.059

2.  [Displacement of a STARflo glaucoma drainage implant with accompanying complications].

Authors:  S Schrittenlocher; A Doulis; K R Koch; A Lappas; L Altay; A-M Lentzsch; C Cursiefen; B Bachmann; V Prokosch-Willing; T Dietlein
Journal:  Ophthalmologe       Date:  2021-04-21       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.